Physician profile
Jonathan D Bratter
NPI 1891904850
$1,005.57
in general payments reported to CMS, 2019-2025
20 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $103 · 2021: $236 · 2022: $66.70 · 2023: $88.00 · 2024: $68.73 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $354.07 | 2019-2021 | |
| Hologic Sales and Service, LLC | $86.47 | 2020-2025 | Aptima |
| Biogen, INC. | $66.85 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $65.94 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $64.62 | 2019-2024 | Slynd |
| Allergan, INC. | $50.49 | 2019 | |
| Therapeuticsmd, INC. | $35.51 | 2021-2022 | |
| Channel Medsystems, INC. | $31.65 | 2023 | |
| Lupin INC. | $31.37 | 2019-2021 | |
| Shield Therapeutics INC | $27.74 | 2025 | |
| Covidien Lp | $24.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.70 | 2019 | |
| Astellas Pharma US INC | $23.50 | 2025 | Veozah |
| Pfizer INC. | $21.68 | 2024 | |
| Gynesonics, INC. | $20.73 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cepheid | $19.40 | 2025 | Genexpert |
| Myovant Sciences INC. | $16.80 | 2021 | |
| Coopersurgical, INC. | $15.22 | 2025 | Paragard T 380a |
| Organon LLC | $14.00 | 2022 | |
| Avion Pharmaceuticals | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bratter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.